All Articles Tagged With: "Wyeth"
Articles
Pfizer Faces Criminal Investigation Over Rapamune Marketing
Federal prosecutors have opened a criminal investigation into Wyeth’s promotions and marketing activities involving the organ transplant drug Rapamune.
Jury Finds Woman’s Breast Cancer Not Caused by Prempro
Breaking a five-case losing streak for Pfizer, Inc., a Philadelphia jury ruled late last week in favor of the drug company and its subsidiary, Wyeth, in a Prempro breast cancer lawsuit. While the jury did find that the company failed to adequately warn about the risk of breast cancer from Prempro, the plaintiff failed [...]
Prempro Lawsuit Results in $9.5M Award for Breast Cancer Survivor
In yet another loss for Pfizer’s Wyeth unit involving side effects of Prempro, a Philadelphia jury awarded $9.45 million this week to an Alabama woman who said that the hormone replacement therapy caused her to develop breast cancer.
Hormone Replacement Therapy Can Increase Asthma Risk: Study
A new study suggests that hormone replacement therapy (HRT) can increase the risk of women developing asthma after menopause. While HRT has long been suspected of increasing the risk of asthma, researchers found that the greatest increase in risk came from the use of estrogen-only HRT therapy.
Prempro Verdict for Punitive Damages Reduced by Judge
A Pennsylvania judge has slashed a jury’s $78.7 million award in a Prempro breast cancer lawsuit, saying that the punitive damage portion of the verdict was excessive.
Generic Reglan Tardive Dyskinesia Lawsuit Not Preempted: Appeals Court
The U.S. Court of Appeals for the Firth Circuit has rejected the argument by a generic drug maker that federal law preempts a state-law failure-to-warn claim filed by a user of their generic Reglan, who developed the rare movement disorder tardive dyskinesia.
Hormone Replacement Therapy Lawsuits Reinstated on Appeal
More than 100 hormone replacement therapy lawsuits filed by women who developed breast cancer after using Prempro and other drugs have been reinstated by a federal appeals court, which ruled that the cases were wrongly thrown out by a lower court in 2008.
23 Hormone Replacement Therapy Breast Cancer Lawsuits Dismissed
A New York judge has dismissed 23 hormone replacement therapy lawsuits filed by women diagnosed with breast cancer, saying that the risk of developing breast cancer from the drugs was well known and that the plaintiffs failed to file their lawsuits within the three-year statute of limitations in New York.
Reglan Lawsuit Over Use of Generics Results in Dismissal of Original Makers
Wyeth, Inc. and Schwarz Pharma, Inc. have been dismissed from a Reglan lawsuit filed by a woman who developed a rare movement disorder, known as tardive dyskinsia, after using a generic version of their gastrointestinal drug. The failure to warn case will now proceed against only the makers of generic Reglan.
Prempro Punitive Damage Awards Totaling $103M Returned by Two Juries
A Philadelphia jury hit subsidiaries of Pfizer, Inc. with $28 million in punitive damages on Monday in a lawsuit over Prempro hormone replacement therapy filed by Donna Kendall. Following the award, the Court unsealed a prior Prempro punitive damage award issued for $75 million in a similar case decided by another Philadelphia jury last [...]
